www.viome.comHealthcare / Healthcare providers & servicesFounded: 2016Funding to Date: $676.37MM
Viome is a direct-to-consumer healthcare company, predicting and preventing chronic diseases through a deeper understanding of an individual's biology at a molecular level. The company analyzes microbial and human gene expressions (mRNA), with technology to provide individuals with health insights and precision nutrition.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/19/2024 | Series D | $25.44MM | $xx.xx | $402.5MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,088,507
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
08/18/2023 | Series C-1 | $46.88MM | $xx.xx | $351.71MM | Khosla Ventures, West River Group, Glico, Physician Partners, Bold Capital Group, Ocgrow Ventures | |
Price per Share
$xx.xx
Shares Outstanding
12,134,016
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Khosla Ventures, West River Group, Glico, Physician Partners, Bold Capital Group, Ocgrow Ventures
|
||||||
08/18/2023 | Series C | $37.1MM | $xx.xx | $351.71MM | Khosla Ventures, West River Group, Glico, Physician Partners, Bold Capital Group, Ocgrow Ventures | |
Price per Share
$xx.xx
Shares Outstanding
6,721,925
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Khosla Ventures, West River Group, Glico, Physician Partners, Bold Capital Group, Ocgrow Ventures
|
||||||
11/12/2019 | Series B | $64.03MM | $xx.xx | $457.36MM | Bold Capital, Physician Partners, Hambrecht Healthcare Growth Venture Fund, Global Infrastructure Partners, Khosla Ventures | |
Price per Share
$xx.xx
Shares Outstanding
5,464,040
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.2x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Bold Capital, Physician Partners, Hambrecht Healthcare Growth Venture Fund, Global Infrastructure Partners, Khosla Ventures
|
||||||
08/02/2017 | Series A | $17.08MM | $xx.xx | $85.42MM | Khosla Ventures, Bold Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
6,490,069
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Khosla Ventures, Bold Capital Partners
|